Carson Wealth (CWM LLC)’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.92K Buy
1,419
+1,314
+1,251% +$5.55K ﹤0.01% 4966
2025
Q4
$0 Sell
105
-135
-56% -$385 ﹤0.01% 5398
2025
Q3
$1K Buy
240
+13
+6% +$47 ﹤0.01% 5089
2025
Q2
$1K Buy
227
+220
+3,143% +$581 ﹤0.01% 4978
2025
Q1
$0 Hold
7
﹤0.01% 5063
2024
Q4
$0 Sell
7
-3
-30% -$24 ﹤0.01% 4924
2024
Q3
$0 Buy
+10
New +$133 ﹤0.01% 4854

Other funds holding CATX

Carson Wealth (CWM LLC)'s CATX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Perspective Therapeutics (CATX) stake by 1,251% in Q1 2026, buying an estimated $5.55K and bringing the position to 1,419 shares worth $5.92K. The position accounts for ﹤0.01% of the portfolio, ranked #4966.

Carson Wealth (CWM LLC) first reported a position in CATX in Q3 2024 and has held it in 7 quarters since. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,419 shares of Perspective Therapeutics worth $5.92K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 1,314 Perspective Therapeutics shares in Q1 2026, an estimated $5.55K.
  • Perspective Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4966 holding.
  • Carson Wealth (CWM LLC) first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.